Health Canada approves drug to treat COVID-19 in immunocompromised patients, AstraZeneca says

Some people in Canada who are particularly vulnerable to illness from COVID-19 have a new treatment option. The antibody-based therapy Evusheld previously used to prevent the virus can now also be used as a treatment.